Clinical trials
catalyst calendar across sponsors →Studies where PH is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional · 2 with posted results
Held by 22 tracked-famous managers (Holocene Advisors, LP, AQR CAPITAL MANAGEMENT LLC, Qube Research & Technologies Ltd, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, +17 more) · FINRA short interest 2.7 days to cover (settled 2026-07-31) · government filings 180d: 8 congress / 6 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Indego Exoskeleton After SCINCT02793635Functional ambulation category (FAC) to measure gait qualityOpen-label · Treatment | Not applicable | Completed | Device: Indego Powered Exoskeleton | Spinal Cord Injury | 9 | Mar 2018actual | 2018-08-31 |
| Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVANCT03054064results2020-04-07Safety of Individuals With Hemiplegia Due to CVA Using the Indego Measured Through Reported Subject Adverse Events and Serious Adverse EventsOpen-label · OtherStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: Indego Exoskeleton | Cerebrovascular Accident (CVA), Stroke, Hemiplegia | 48 | 2017-12-28actual | 2020-04-07 |
| Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).NCT02202538results2016-12-20Percentage of Subjects Able to Complete the 600 Meter Walk Test (600MWT)Open-label · Treatment | Not applicable | Completed | Device: Indego | Spinal Cord Injury | 53 | Oct 2015actual | 2017-07-25 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19